3.50pm – 4.30pm, 30 September 2026 ‐ 40 mins
Panel Q&A

Head of Market Impact SAP Signavio & LeanIX, SAP



Director, Enterprise Architecture, AstraZeneca
|
Oliver is an experienced transformation leader with over a decade of hands‑on delivery across major business programmes underpinned by SAP S/4HANA and its supporting applications. Over the last 10+ years, he has held leadership roles throughout the full programme lifecycle, including Enterprise Architecture, Programme Management, Business Analysis, UAT leadership, and roles in communications, change and adoption. Oliver currently serves as Director, Enterprise Architecture at AstraZeneca, where he is responsible for defining and governing the strategic direction of the enterprise Integrated Toolchain, as well as taking direct responsibility for AstraZeneca’s implementation of SAP’s Business Transformation Management (BTM) suite, including LeanIX, Signavio and WalkMe.
|

Head of AI and Innovation, EMEA, Syniti
Kevin Wild is Head of AI & Innovation for EMEA at Syniti, where he helps organisations harness the power of trusted data, artificial intelligence and innovation to accelerate complex business transformation programmes. With deep expertise spanning data management, governance, quality and migration, he works with global enterprises to translate emerging technologies into tangible business outcomes.
Bringing more than a decade of experience across multinational organisations including Asahi, Coty and SABMiller, Kevin has supported large-scale transformation initiatives across industries and geographies. His career reflects a strong track record of helping businesses unlock greater value from their data to support transformation and growth.